跳至主要内容
临床试验/ACTRN12618000106235
ACTRN12618000106235招募中4 期

The Adjunctive Lithium for Acute Suicidality (ALiAS) Trial: A randomised controlled trial examining the effect of adjunctive lithium on acute suicidality in patients with a mood disorder

The University of Sydney0 个研究点目标入组 120 人开始时间: 2018年1月24日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Participants will be eligible to take part in the ALiAS Trial if they are:
  • - Aged 18-65 years
  • - Meet DSM-5 criteria for a mood disorder
  • - Currently receiving treatment for a mood disorder
  • - Presenting with suicidality as defined by a score of greater than 8 on the S-STS scale
  • - Not currently receiving lithium treatment and their treating doctor does not intend to prescribe lithium during the course of the study
  • - Willing and able to comply to the trial protocol in English
  • - Willing and able to give written informed consent in English

排除标准

  • Participants will be not be eligible to take part in the ALiAS Trial if they:
  • - Are not receiving treatment for a mood disorder
  • - Have used lithium in the past 6 months
  • - Meet criteria for personality disorder or substance dependency disorder in accordance with DSM-5 criteria
  • - Have contraindication for lithium therapy including heart conditions, thyroid, hepatic, renal dysfunction (as checked by blood tests)
  • - Are pregnant (as checked by blood test) or breastfeeding or are of child-bearing potential and not willing to use effective contraception
  • - Have participated in another research trial involving an investigational medical product in the past 12 weeks

研究者

相似试验